Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-06

Clinical Trial Update: Empagliflozin in Heart Failure Dialysis Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating empagliflozin in heart failure patients on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Heart Failure, Hemodialysis | NA | Status: COMPLETED